BHVN
Biohaven Ltd.
13.20$
-3.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +34.1% | -18.4% | +39.2% | -12.4% | +20.5% | -25.4% | +19.9% | -25.7% | +10.3% | +3.3% | -20.5% | |
| – | +42.5% | -21.2% | +46.6% | -13.8% | +22.2% | -28.9% | +24.1% | -31.8% | +13.8% | +4.7% | -23.1% | |
| – | +122.4% | -26.4% | +30.9% | -64.7% | +17.5% | -0.7% | +68.5% | +11.5% | +24.4% | +18.8% | -12.8% | |
| – | +58.7% | -25.8% | +54.2% | -13.3% | +28.3% | -33.6% | +25.5% | -35.7% | +22.6% | +9.0% | -23.0% | |
| – | -11.1% | -36.4% | -10.8% | -29.3% | -51.2% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -0.6% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -8.1% | +37.4% | +69.9% | -2.2% | -1.5% | +4.1% | +108.5% | +2.5% | -6.3% | -15.6% | +6.4% | |
| – | -10.9% | +56.2% | +80.4% | -2.5% | +1.3% | +6.4% | -24.2% | -9.1% | +2.6% | -55.1% | +20.3% | |
| – | +0.8% | +4.1% | +3.0% | +3.5% | +3.4% | +23.8% | -0.3% | +17.4% | +4.4% | +2.5% | -20.9% | |
| – | +63.7% | +133.6% | -52.6% | +14.4% | -8.7% | +6.2% | +2.5% | -10.9% | -33.4% | -10.5% | +16.2% | |
| – | – | – | – | – | – | – | – | +4.4% | -10.9% | +1.3% | +7.3% | |
| – | +47.6% | -29.6% | +27.3% | -17.7% | +34.0% | -38.7% | -48.1% | -112.8% | – | +148.7% | -90.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +17.0% | +2.1% | +7.6% | +7.5% | +7.1% | +0.9% | +0.4% | +3.4% | +13.6% | +22.8% | +2.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.